HQY Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
354.6M
+6.0%
334.6M
+3.9%
322.2M
-1.1%
325.8M
-1.5%
330.8M
Cost of Revenue
98.3M
-7.6%
106.4M
+13.1%
94.1M
+0.9%
93.2M
-12.5%
106.5M
Gross Profit
256.3M
+12.3%
228.1M
+0.0%
228.1M
-1.9%
232.6M
+3.7%
224.3M
Operating Expenses
153.4M
-2.4%
157.1M
+5.2%
149.4M
+4.5%
143.0M
+1.2%
141.2M
R&D
67.8M
-3.7%
70.4M
+6.7%
65.9M
+1.7%
64.8M
+5.5%
61.4M
SG&A
58.0M
-0.8%
58.5M
+5.7%
55.3M
+10.8%
49.9M
-3.1%
51.5M
Operating Income
103.0M
+44.9%
71.1M
-9.7%
78.7M
-12.2%
89.6M
+7.9%
83.1M
EBITDA
142.3M
+28.1%
111.1M
-6.4%
118.6M
-8.3%
129.3M
+5.1%
123.1M
Net Income
69.4M
+39.6%
49.7M
-3.8%
51.7M
-13.6%
59.9M
+11.0%
53.9M
EPS (Basic)
$0.82
+41.4%
$0.58
-3.3%
$0.60
-13.0%
$0.69
+11.3%
$0.62
EPS (Diluted)
$0.82
+43.9%
$0.57
-3.4%
$0.59
-13.2%
$0.68
+11.5%
$0.61
Shares (Diluted)
85.0M
-2.0%
86.8M
-0.2%
87.0M
-0.9%
87.7M
-0.8%
88.4M
HealthEquity (HQY) โ€” Financials